Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor.
作者信息
Bataller L, Galiano R, García-Escrig M, Martínez B, Sevilla T, Blasco R, Vílchez J J, Dalmau J
机构信息
Service of Neurology, Hospital Universitari la Fe, Avenida de Campanar 21, 46009 Valencia, Spain.
出版信息
Neurology. 2010 Jan 19;74(3):265-7. doi: 10.1212/WNL.0b013e3181cb3e52.
Abstract
摘要
相似文献
1
Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor.
Neurology. 2010 Jan 19;74(3):265-7. doi: 10.1212/WNL.0b013e3181cb3e52.
2
Treatment of VGKC complex antibody-associated limbic encephalitis: a systematic review.
J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):264-71. doi: 10.1176/appi.neuropsych.13020022.
3
Limbic encephalitis in children and adolescents.
Arch Dis Child. 2011 Feb;96(2):186-91. doi: 10.1136/adc.2010.183897. Epub 2010 Oct 19.
4
Limbic encephalitis with mGluR5 antibodies and immunotherapy-responsive prosopagnosia.
Neurology. 2014 Oct 7;83(15):1384-6. doi: 10.1212/WNL.0000000000000865. Epub 2014 Sep 5.
5
[Anti-Ma2, anti-NMDA-receptor and anti-GluRε2 limbic encephalitis with testicular seminoma: short-term memory disturbance].
Rinsho Shinkeigaku. 2012;52(9):666-71. doi: 10.5692/clinicalneurol.52.666.
6
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy.
Eur J Paediatr Neurol. 2018 Jan;22(1):190-193. doi: 10.1016/j.ejpn.2017.08.004. Epub 2017 Sep 2.
7
Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors.
J Neurosci. 2013 Nov 13;33(46):18161-74. doi: 10.1523/JNEUROSCI.3506-13.2013.
8
Autoimmune Limbic Encephalitis Associated with Type 1 Diabetes Mellitus.
J Clin Res Pediatr Endocrinol. 2017 Dec 15;9(4):387-388. doi: 10.4274/jcrpe.3818. Epub 2017 Jul 17.
9
An Uncommon Presentation of a Primary Bone Tumor: Anti-AMPA (Anti-α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid) Receptor Limbic/Paraneoplastic Encephalitis as a Presenting Feature of Ewing Sarcoma.
J Pediatr Hematol Oncol. 2018 Oct;40(7):555-557. doi: 10.1097/MPH.0000000000001304.
10
Autoantibodies against glutamate receptor epsilon2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis.
Eur Neurol. 2007;58(3):152-8. doi: 10.1159/000104716. Epub 2007 Jun 29.
引用本文的文献
1
Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 2 encephalitis with olfactory hallucination: a case report and literature review.
Front Immunol. 2025 Feb 20;16:1444053. doi: 10.3389/fimmu.2025.1444053. eCollection 2025.
2
Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1 antibodies: a case report and literature review.
Neurol Sci. 2025 May;46(5):1995-2005. doi: 10.1007/s10072-024-07843-8. Epub 2025 Jan 17.
3
Thymoma-associated autoimmune encephalitis with myasthenia gravis: Case series and literature review.
CNS Neurosci Ther. 2024 Feb;30(2):e14568. doi: 10.1111/cns.14568.
4
Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis developed after ovarian cancer cytoreduction surgery: a case report and literature review.
BMC Womens Health. 2023 Sep 21;23(1):507. doi: 10.1186/s12905-023-02636-1.
5
Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis.
Neurol Sci. 2023 Sep;44(9):3253-3259. doi: 10.1007/s10072-023-06769-x. Epub 2023 Apr 3.
6
Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.
Front Immunol. 2021 May 21;12:652820. doi: 10.3389/fimmu.2021.652820. eCollection 2021.
7
Clinical Review and Prognostic Analysis of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptor-Associated Encephalitis.
Front Neurol. 2021 May 13;12:665229. doi: 10.3389/fneur.2021.665229. eCollection 2021.
8
Significance of Autoantibodies in Autoimmune Encephalitis in Relation to Antigen Localization: An Outline of Frequently Reported Autoantibodies with a Non-Systematic Review.
Int J Mol Sci. 2020 Jul 13;21(14):4941. doi: 10.3390/ijms21144941.
9
Experimental Models of Neuroimmunological Disorders: A Review.
Front Neurol. 2020 May 12;11:389. doi: 10.3389/fneur.2020.00389. eCollection 2020.
10
Paraneoplastic Diseases of the Central Nervous System.
F1000Res. 2020 Mar 6;9. doi: 10.12688/f1000research.21309.1. eCollection 2020.
本文引用的文献
1
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.
Ann Neurol. 2009 Apr;65(4):424-34. doi: 10.1002/ana.21589.
2
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Lancet Neurol. 2008 Dec;7(12):1091-8. doi: 10.1016/S1474-4422(08)70224-2. Epub 2008 Oct 11.
3
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations.
Neurology. 2008 Sep 16;71(12):930-6. doi: 10.1212/01.wnl.0000325917.48466.55.
4
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.
Brain. 2005 Aug;128(Pt 8):1764-77. doi: 10.1093/brain/awh526. Epub 2005 May 11.
5
Clinical analysis of anti-Ma2-associated encephalitis.
Brain. 2004 Aug;127(Pt 8):1831-44. doi: 10.1093/brain/awh203. Epub 2004 Jun 23.
6
Synaptic plasticity and AMPA receptor trafficking.
Ann N Y Acad Sci. 2003 Nov;1003:1-11. doi: 10.1196/annals.1300.001.
7
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
Brain. 2000 Jul;123 ( Pt 7):1481-94. doi: 10.1093/brain/123.7.1481.
Zotero 插件